All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
MRNA real return snapshot: after CPI-U inflation, MRNA returned +701.12% over the past year and +572.18% YTD, with dividends reinvested. Since Dec. 7, 2018, MRNA is up +728.30% in real purchasing-power return, or +30.49%/yr, and is currently â65.51% below its real total-return high on Aug. 9, 2021.
Data ending Tue Nov. 17, 2026
| Fri 2018-12-07đŹ to Tue 2026-11-17 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+728.30%
+30.49%/yr |
+1.69%/yr
R2=0.002 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07đŹ to Tue 2026-11-17 |
Start
Value |
End
Value |
|---|---|---|
| MRNA × |
$10,000.00
2018-12-07 |
$82,830.42
2026-11-17 |
| YTD | YoY | |
|---|---|---|
| MRNA × | +572.18% | +701.12% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| MRNA × |
â65.51%
on 2026-11-17 from 2021-08-09 peak |
â96.11%
on 2025-11-20 from 2021-08-09 peak |
| Period ending Tue 2026-11-17 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| MRNA × | +701.12% |
+423.86% +128.88%/yr |
+145.93% +34.98%/yr |
â29.96% â6.87%/yr |
— |
| Year | MRNA |
|---|---|
| 2026 (YTD) | +572.18% |
| 2025 | â30.92% |
| 2024 | â59.36% |
| 2023 | â46.43% |
| 2022 | â33.57% |
| 2021 | +127.13% |
| 2020 | +426.92% |
| 2019 | +25.23% |
| 2018 | â17.70% |